167 related articles for article (PubMed ID: 18945969)
1. Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.
Mhyre AJ; Marcondes AM; Spaulding EY; Deeg HJ
Blood; 2009 Jan; 113(3):649-58. PubMed ID: 18945969
[TBL] [Abstract][Full Text] [Related]
2. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.
Li X; Marcondes AM; Gooley TA; Deeg HJ
Blood; 2010 Sep; 116(13):2304-14. PubMed ID: 20562331
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?
Stirewalt DL; Mhyre AJ; Marcondes M; Pogosova-Agadjanyan E; Abbasi N; Radich JP; Deeg HJ
Br J Haematol; 2008 Feb; 140(4):444-53. PubMed ID: 18162123
[TBL] [Abstract][Full Text] [Related]
4. Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis.
Marcondes AM; Li X; Gooley TA; Milless B; Deeg HJ
Blood; 2010 Mar; 115(10):1993-2002. PubMed ID: 20061558
[TBL] [Abstract][Full Text] [Related]
5. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
[TBL] [Abstract][Full Text] [Related]
6. Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells.
Platzbecker U; Ward JL; Deeg HJ
Br J Haematol; 2003 Aug; 122(3):489-97. PubMed ID: 12877678
[TBL] [Abstract][Full Text] [Related]
7. Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Peddie CM; Bowen DT; Pippard MJ
Leukemia; 2002 May; 16(5):785-90. PubMed ID: 11986938
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).
Kerbauy DM; Lesnikov V; Abbasi N; Seal S; Scott B; Deeg HJ
Blood; 2005 Dec; 106(12):3917-25. PubMed ID: 16105982
[TBL] [Abstract][Full Text] [Related]
9. Altered susceptibility to apoptosis and N‑glycan profiles of hematopoietic KG1a cells following co‑culture with bone marrow‑derived stromal cells under hypoxic conditions.
Pang X; Wang Y; Zhang S; Tan Z; Guo J; Guan F; Li X
Oncol Rep; 2018 Sep; 40(3):1477-1486. PubMed ID: 30015888
[TBL] [Abstract][Full Text] [Related]
10. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.
Marcondes AM; Mhyre AJ; Stirewalt DL; Kim SH; Dinarello CA; Deeg HJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2865-70. PubMed ID: 18287021
[TBL] [Abstract][Full Text] [Related]
12. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
13. Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.
Claessens YE; Park S; Dubart-Kupperschmitt A; Mariot V; Garrido C; Chrétien S; Dreyfus F; Lacombe C; Mayeux P; Fontenay M
Blood; 2005 May; 105(10):4035-42. PubMed ID: 15677568
[TBL] [Abstract][Full Text] [Related]
14. Dual role of TMS1/ASC in death receptor signaling.
Parsons MJ; Vertino PM
Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133
[TBL] [Abstract][Full Text] [Related]
15. Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells.
Sato T; Selleri C; Anderson S; Young NS; Maciejewski JP
Br J Haematol; 1997 May; 97(2):356-65. PubMed ID: 9163602
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
[TBL] [Abstract][Full Text] [Related]
17. Effects of thalidomide on long-term bone marrow cultures from patients with myelodysplastic syndromes: induction of IL-10 expression in the stromal layers.
Lazarini M; Traina F; Winnischofer SM; Costa FF; Queiroz ML; Saad ST
Leuk Res; 2011 Aug; 35(8):1102-7. PubMed ID: 21511336
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O
Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046
[TBL] [Abstract][Full Text] [Related]
19. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.
Gersuk GM; Beckham C; Loken MR; Kiener P; Anderson JE; Farrand A; Troutt AB; Ledbetter JA; Deeg HJ
Br J Haematol; 1998 Oct; 103(1):176-88. PubMed ID: 9792306
[TBL] [Abstract][Full Text] [Related]
20. Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.
Seal S; Hockenbery DM; Spaulding EY; Kiem HP; Abbassi N; Deeg HJ
Exp Hematol; 2008 Dec; 36(12):1660-72. PubMed ID: 18838202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
